Skin inflammation driven by differentiation of quiescent tissue-resident ILCs into a spectrum of pathogenic effectors
Authors:
- Piotr BieleckiPBPiotr Bielecki
- Samantha J. RiesenfeldSRSamantha J. Riesenfeld
- Monika S. KowalczykMKMonika S. Kowalczyk
- Maria C. Amezcua VeselyMVMaria C. Amezcua Vesely
- Lina KroehlingLKLina Kroehling
- Parastou YaghoubiPYParastou Yaghoubi
- Danielle DionneDDDanielle Dionne
- Abigail JarretAJAbigail Jarret
- Holly R. SteachHSHolly R. Steach
- Heather M. McGeeHMHeather M. McGee
- Caroline B. M. PorterCPCaroline B. M. Porter
- Paula Licona-LimonPLPaula Licona-Limon
Preprint
Abstract
Psoriasis pathology is driven by the type 3 cytokines IL-17 and Il-22, but little is understood about the dynamics that initiate alterations in tissue homeostasis. Here, we use mouse models, single-cell RNA-seq (scRNA-seq), computational inference and cell lineage mapping to show that psoriasis induction reconfigures the functionality of skin-resident ILCs to initiate disease. Tissue-resident ILCs amplified an initial IL-23 trigger and were sufficient, without circulatory ILCs, to drive pathology, indicating that ILC tissue remodeling initiates psoriasis. Skin ILCs expressed type 2 cytokines IL-5 and IL-13 in steady state, but were epigenetically poised to become ILC3-like cells. ScRNA-seq profiles of ILCs from psoriatic and naïve skin of wild type (WT) and Rag1 -/- mice form a dense continuum, consistent with this model of fluid ILC states. We inferred biological “topics” underlying these states and their relative importance in each cell with a generative model of latent Dirichlet allocation, showing that ILCs from untreated skin span a spectrum of states, including a naïve/quiescent-like state and one expressing the Cd74 and Il13 but little Il5 . Upon disease induction, this spectrum shifts, giving rise to a greater proportion of classical Il5- and Il13- expressing “ILC2s” and a new, mixed ILC2/ILC3-like subset, expressing Il13, Il17, and Il22 . Using these key topics, we related the cells through transitions, revealing a quiescence-ILC2-ILC3s state trajectory. We demonstrated this plasticity in vivo , combining an IL-5 fate mouse with IL-17A and IL-22 reporters, validating the transition of IL-5–producing ILC2s to IL-22– and IL-17A–producing cells during disease initiation. Thus, steady-state skin ILCs are actively repressed and cued for a plastic, type 2 response, which, upon induction, morphs into a type 3 response that drives psoriasis. This suggests a general model where specific immune activities are primed in healthy tissue, dynamically adapt to provocations, and left unchecked, drive pathological remodeling.Keywords
All Related Versions
- Published version: Nature, 592 (7852), 128.
This publication has 62 references indexed in Scilit:
- Integrating single-cell transcriptomic data across different conditions, technologies, and speciesNature Biotechnology, 2018
- Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cellsNature, 2018
- IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungsNature Immunology, 2016
- destiny: diffusion maps for large-scale single-cell data in RBioinformatics, 2015
- Interleukin-12 and -23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina PropriaImmunity, 2015
- Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome positionNature Methods, 2013
- DeMix: deconvolution for mixed cancer transcriptomes using raw measured dataBioinformatics, 2013
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Role of Krüppel-like factors in leukocyte development, function, and diseaseBlood, 2010
- Kruppel-like factor 2 regulates thymocyte and T-cell migrationNature, 2006